(ATDN) Treatment Briefs: Lobucavir for CMV

(ATDN) Treatment Briefs: Lobucavir for CMV

Treatment Review No. 23 - December 1996

A new drug called lobucavir is being studied for the treatment of newly diagnosed CMV retinitis. CMV retinitis is an infection caused by a herpesvirus that people with low T4 cells can get. If untreated, the infection leads to blindness. Lobucavir is an antiviral drug that is active against many different herpesviruses, as well as HIV. In an early study, lobucavir reduced the amount of HIV in the blood by over 90%. Lobucavir is a pill that is taken 4 times a day. Call the Network if you'd like a referral to the study site.

961201
ATR02308

Always watch for outdated information. This article first appeard in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1996 - AIDS Treatment Data Network. If you want to copy, reproduce or excerpt this information, please give us a call at (800) 734-7104. This helps up to keep track of where and how this information is being used. You can also Email us at network@atdn.org http://206.179.124.69/network/index.html

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1996. AEGIS.